Stratus Medical | $10,000,000 | (Feb 5, 2026)
Derapi | $7,000,000 | (Feb 4, 2026)
enclaive | $4,849,418 | (Feb 4, 2026)
Certified by Founder
Lodge
Moonwalk Biosciences
start up
United States
- South San Francisco, California
- 08/01/2024
- Series A
- $57,000,000
Moonwalk Biosciences is an early-stage therapeutics company co-founded by Dr. Feng Zhang and leading experts in cell state epigenetics including Alex Aravanis, the former CTO of Illumina. The company has developed a differentiated approach to mapping the epigenome of cellular states at the whole genome, single cell resolution level, as well as proprietary strategies for precise epigenetic engineering. The combination enables both a novel discovery platform and a path to developing therapeutics that include both epigenetic engineering and other traditional modalities.
- Industry Biotechnology Research
- Website https://moonwalk.bio/
- LinkedIn https://www.linkedin.com/company/moonwalk-biosciences/about/
OneDome | $25,000,000 | (Feb 4, 2026)
ecovia I bio | Undisclosed Amount | (Feb 4, 2026)
AIRRIVED | $6,100,000 | (Feb 4, 2026)
Naoma AI | $440,000 | (Feb 4, 2026)
MaiaEdge | $20,000,000 | (Feb 4, 2026)
Mitra EV | $27,000,000 | (Feb 4, 2026)
Arbor(US) | $6,300,000 | (Feb 4, 2026)
Graici | $7,500,000 | (Feb 4, 2026)
Breezy | $10,000,000 | (Feb 3, 2026)